 David Bortz
Concepts (234)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Models, Biological | 15 | 2023 | 1630 | 2.760 |
Why?
| | Prefrontal Cortex | 5 | 2023 | 262 | 2.350 |
Why?
| | Ventral Tegmental Area | 4 | 2023 | 45 | 2.240 |
Why?
| | Dopaminergic Neurons | 4 | 2023 | 43 | 2.220 |
Why?
| | Glutamic Acid | 5 | 2017 | 211 | 1.810 |
Why?
| | Substantia Nigra | 3 | 2022 | 38 | 1.450 |
Why?
| | Mathematical Concepts | 4 | 2023 | 24 | 1.270 |
Why?
| | Klebsiella pneumoniae | 6 | 2012 | 41 | 1.000 |
Why?
| | Nonlinear Dynamics | 3 | 2023 | 83 | 0.960 |
Why?
| | Computer Simulation | 11 | 2018 | 878 | 0.800 |
Why?
| | Electrolysis | 1 | 2020 | 2 | 0.730 |
Why?
| | Models, Theoretical | 7 | 2020 | 516 | 0.730 |
Why?
| | Nucleus Accumbens | 3 | 2017 | 124 | 0.720 |
Why?
| | Methane | 1 | 2020 | 41 | 0.710 |
Why?
| | Reversal Learning | 2 | 2019 | 10 | 0.700 |
Why?
| | Dopamine | 1 | 2022 | 236 | 0.680 |
Why?
| | Septal Nuclei | 1 | 2019 | 16 | 0.660 |
Why?
| | Keratinocytes | 2 | 2021 | 216 | 0.660 |
Why?
| | Septum of Brain | 1 | 2018 | 3 | 0.610 |
Why?
| | Algorithms | 5 | 2023 | 1468 | 0.600 |
Why?
| | Software | 2 | 2023 | 536 | 0.600 |
Why?
| | Heat-Shock Proteins | 1 | 2018 | 113 | 0.590 |
Why?
| | Longevity | 1 | 2018 | 137 | 0.570 |
Why?
| | Transaminases | 1 | 2017 | 25 | 0.570 |
Why?
| | alpha7 Nicotinic Acetylcholine Receptor | 2 | 2016 | 96 | 0.550 |
Why?
| | N-Methylaspartate | 4 | 2018 | 37 | 0.550 |
Why?
| | Rats | 6 | 2023 | 4943 | 0.540 |
Why?
| | Biofilms | 5 | 2013 | 223 | 0.540 |
Why?
| | Isoxazoles | 1 | 2016 | 52 | 0.530 |
Why?
| | Anilides | 1 | 2016 | 67 | 0.530 |
Why?
| | Caenorhabditis elegans Proteins | 1 | 2018 | 180 | 0.530 |
Why?
| | Bacterial Adhesion | 2 | 2013 | 78 | 0.510 |
Why?
| | Choline | 1 | 2016 | 106 | 0.510 |
Why?
| | Caenorhabditis elegans | 1 | 2018 | 269 | 0.500 |
Why?
| | Rats, Wistar | 5 | 2017 | 368 | 0.490 |
Why?
| | Wound Healing | 2 | 2021 | 258 | 0.490 |
Why?
| | Chondroitin Sulfates | 1 | 2014 | 33 | 0.470 |
Why?
| | Electrochemistry | 1 | 2014 | 79 | 0.470 |
Why?
| | Microspheres | 1 | 2014 | 123 | 0.460 |
Why?
| | Patient-Specific Modeling | 1 | 2014 | 36 | 0.460 |
Why?
| | Metabolic Networks and Pathways | 1 | 2015 | 168 | 0.450 |
Why?
| | Hippocampus | 2 | 2018 | 695 | 0.450 |
Why?
| | Enzyme Inhibitors | 1 | 2017 | 751 | 0.450 |
Why?
| | Excitatory Amino Acid Agonists | 3 | 2018 | 37 | 0.430 |
Why?
| | Cell Movement | 2 | 2021 | 867 | 0.430 |
Why?
| | Dictyostelium | 1 | 2012 | 11 | 0.430 |
Why?
| | Biophysics | 1 | 2012 | 70 | 0.410 |
Why?
| | Nicotinic Agonists | 1 | 2013 | 100 | 0.400 |
Why?
| | Bridged Bicyclo Compounds, Heterocyclic | 1 | 2013 | 172 | 0.400 |
Why?
| | Kinetics | 5 | 2016 | 1550 | 0.390 |
Why?
| | Animals | 15 | 2023 | 31762 | 0.390 |
Why?
| | HIV-1 | 3 | 2006 | 768 | 0.390 |
Why?
| | Receptors, Nicotinic | 1 | 2013 | 274 | 0.370 |
Why?
| | Cartilage, Articular | 1 | 2014 | 289 | 0.370 |
Why?
| | Microfluidics | 1 | 2011 | 45 | 0.370 |
Why?
| | Precision Medicine | 1 | 2014 | 338 | 0.360 |
Why?
| | Mechanotransduction, Cellular | 1 | 2011 | 97 | 0.350 |
Why?
| | Polyethylene Glycols | 1 | 2014 | 561 | 0.340 |
Why?
| | Systems Biology | 2 | 2023 | 56 | 0.330 |
Why?
| | Cyanobacteria | 2 | 2020 | 54 | 0.330 |
Why?
| | HIV Infections | 5 | 2006 | 2469 | 0.320 |
Why?
| | Signal Transduction | 3 | 2018 | 4522 | 0.320 |
Why?
| | Movement | 1 | 2011 | 244 | 0.320 |
Why?
| | Flocculation | 3 | 2013 | 7 | 0.280 |
Why?
| | Staphylococcus epidermidis | 3 | 2013 | 71 | 0.280 |
Why?
| | Neural Pathways | 2 | 2019 | 261 | 0.270 |
Why?
| | HIV | 2 | 2004 | 208 | 0.270 |
Why?
| | Diabetes Mellitus | 1 | 2014 | 904 | 0.270 |
Why?
| | Reverse Transcriptase Inhibitors | 1 | 2006 | 82 | 0.260 |
Why?
| | Kynurenine | 2 | 2017 | 80 | 0.250 |
Why?
| | Blood Glucose | 1 | 2014 | 1821 | 0.250 |
Why?
| | Population Dynamics | 2 | 2017 | 128 | 0.240 |
Why?
| | Rats, Sprague-Dawley | 2 | 2019 | 2209 | 0.220 |
Why?
| | Pars Compacta | 1 | 2023 | 4 | 0.220 |
Why?
| | Elasticity | 2 | 2014 | 189 | 0.220 |
Why?
| | Complement C5a | 2 | 2013 | 59 | 0.210 |
Why?
| | Hydrodynamics | 2 | 2013 | 37 | 0.210 |
Why?
| | Numerical Analysis, Computer-Assisted | 3 | 2014 | 17 | 0.210 |
Why?
| | Bacteremia | 4 | 2013 | 159 | 0.210 |
Why?
| | Bicuculline | 1 | 2022 | 21 | 0.210 |
Why?
| | Scopolamine Derivatives | 1 | 2022 | 6 | 0.210 |
Why?
| | Models, Statistical | 1 | 2006 | 604 | 0.210 |
Why?
| | Cognition | 2 | 2023 | 989 | 0.200 |
Why?
| | Ligands | 2 | 2014 | 565 | 0.200 |
Why?
| | Male | 8 | 2023 | 55579 | 0.200 |
Why?
| | Adherens Junctions | 1 | 2021 | 26 | 0.200 |
Why?
| | Hydrogen | 1 | 2020 | 60 | 0.180 |
Why?
| | Bioreactors | 1 | 2020 | 43 | 0.180 |
Why?
| | Disease Transmission, Infectious | 1 | 2020 | 56 | 0.170 |
Why?
| | Kynurenic Acid | 2 | 2017 | 10 | 0.170 |
Why?
| | Communicable Disease Control | 1 | 2020 | 67 | 0.170 |
Why?
| | Photosynthesis | 1 | 2020 | 76 | 0.160 |
Why?
| | Peptide Hormones | 1 | 2018 | 8 | 0.160 |
Why?
| | Receptor, Insulin | 1 | 2018 | 93 | 0.150 |
Why?
| | Heat-Shock Response | 1 | 2018 | 46 | 0.150 |
Why?
| | Amphetamine | 1 | 2018 | 22 | 0.150 |
Why?
| | Globus Pallidus | 1 | 2018 | 17 | 0.150 |
Why?
| | Dopamine Uptake Inhibitors | 1 | 2018 | 54 | 0.150 |
Why?
| | Hydrophobic and Hydrophilic Interactions | 1 | 2018 | 176 | 0.150 |
Why?
| | Animals, Genetically Modified | 1 | 2018 | 215 | 0.150 |
Why?
| | Betacoronavirus | 1 | 2020 | 252 | 0.140 |
Why?
| | Microdialysis | 1 | 2017 | 49 | 0.140 |
Why?
| | Drug Administration Routes | 1 | 2017 | 40 | 0.140 |
Why?
| | Heterocyclic Compounds, 3-Ring | 1 | 2017 | 28 | 0.140 |
Why?
| | Time Factors | 4 | 2016 | 6124 | 0.140 |
Why?
| | Electrodes | 1 | 2017 | 100 | 0.140 |
Why?
| | Bacterial Proteins | 2 | 2020 | 739 | 0.140 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2018 | 350 | 0.140 |
Why?
| | Central Nervous System Stimulants | 1 | 2018 | 139 | 0.140 |
Why?
| | Allosteric Regulation | 1 | 2016 | 82 | 0.130 |
Why?
| | alpha Catenin | 1 | 2016 | 13 | 0.130 |
Why?
| | Thiazolidinediones | 1 | 2017 | 142 | 0.130 |
Why?
| | Phenylurea Compounds | 1 | 2016 | 84 | 0.130 |
Why?
| | Pandemics | 2 | 2021 | 1319 | 0.130 |
Why?
| | Epidermal Growth Factor | 1 | 2016 | 162 | 0.130 |
Why?
| | Pneumonia, Viral | 1 | 2020 | 340 | 0.130 |
Why?
| | Coronavirus Infections | 1 | 2020 | 332 | 0.120 |
Why?
| | Biochemical Phenomena | 1 | 2015 | 10 | 0.120 |
Why?
| | Probability | 2 | 2014 | 291 | 0.120 |
Why?
| | Insulin | 2 | 2015 | 2079 | 0.120 |
Why?
| | Administration, Oral | 1 | 2017 | 731 | 0.120 |
Why?
| | Adhesiveness | 1 | 2014 | 19 | 0.120 |
Why?
| | Salts | 1 | 2014 | 36 | 0.120 |
Why?
| | Exocytosis | 1 | 2015 | 89 | 0.120 |
Why?
| | Cell Adhesion | 1 | 2016 | 430 | 0.120 |
Why?
| | Sulfates | 1 | 2014 | 43 | 0.120 |
Why?
| | Osmolar Concentration | 1 | 2014 | 173 | 0.120 |
Why?
| | Bacteria | 1 | 2020 | 726 | 0.120 |
Why?
| | Static Electricity | 1 | 2014 | 114 | 0.120 |
Why?
| | Gels | 1 | 2014 | 72 | 0.120 |
Why?
| | Calibration | 1 | 2014 | 125 | 0.120 |
Why?
| | Solutions | 1 | 2014 | 146 | 0.120 |
Why?
| | Microelectrodes | 1 | 2014 | 32 | 0.120 |
Why?
| | Biological Clocks | 1 | 2014 | 37 | 0.120 |
Why?
| | RNA Interference | 1 | 2016 | 437 | 0.120 |
Why?
| | Sodium Channel Blockers | 1 | 2014 | 23 | 0.120 |
Why?
| | Tetrodotoxin | 1 | 2014 | 39 | 0.120 |
Why?
| | Diffusion | 1 | 2014 | 119 | 0.120 |
Why?
| | Solvents | 1 | 2014 | 105 | 0.120 |
Why?
| | Sulfonylurea Compounds | 1 | 2014 | 44 | 0.110 |
Why?
| | Analysis of Variance | 1 | 2017 | 1226 | 0.110 |
Why?
| | Staphylococcal Infections | 3 | 2013 | 336 | 0.110 |
Why?
| | Virus Replication | 3 | 2004 | 395 | 0.110 |
Why?
| | Cross-Linking Reagents | 1 | 2014 | 181 | 0.110 |
Why?
| | Catheters, Indwelling | 1 | 2014 | 79 | 0.110 |
Why?
| | Intestinal Mucosa | 1 | 2018 | 530 | 0.110 |
Why?
| | Biological Evolution | 1 | 2017 | 416 | 0.110 |
Why?
| | Electrodes, Implanted | 1 | 2014 | 91 | 0.110 |
Why?
| | Motor Activity | 1 | 2018 | 640 | 0.110 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2014 | 511 | 0.110 |
Why?
| | Schizophrenia | 2 | 2014 | 415 | 0.110 |
Why?
| | Internet | 1 | 2017 | 596 | 0.110 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2017 | 1846 | 0.100 |
Why?
| | Bacterial Physiological Phenomena | 1 | 2013 | 57 | 0.100 |
Why?
| | ErbB Receptors | 1 | 2016 | 560 | 0.100 |
Why?
| | Animal Distribution | 1 | 2012 | 20 | 0.100 |
Why?
| | Moths | 1 | 2012 | 35 | 0.100 |
Why?
| | Animals, Newborn | 1 | 2014 | 777 | 0.100 |
Why?
| | Humans | 14 | 2021 | 114757 | 0.100 |
Why?
| | Water | 1 | 2014 | 399 | 0.100 |
Why?
| | Drug Resistance, Bacterial | 1 | 2012 | 155 | 0.090 |
Why?
| | Insulin-Secreting Cells | 1 | 2015 | 317 | 0.090 |
Why?
| | Bacterial Capsules | 1 | 2011 | 28 | 0.090 |
Why?
| | Disease Models, Animal | 2 | 2014 | 3542 | 0.090 |
Why?
| | Metformin | 1 | 2014 | 277 | 0.090 |
Why?
| | Polymers | 1 | 2014 | 447 | 0.090 |
Why?
| | Immunity, Innate | 2 | 2013 | 723 | 0.090 |
Why?
| | Cell Line | 1 | 2016 | 2639 | 0.090 |
Why?
| | Cell Count | 1 | 2011 | 305 | 0.090 |
Why?
| | Computational Biology | 1 | 2013 | 530 | 0.080 |
Why?
| | Gene Expression Regulation | 1 | 2018 | 2321 | 0.080 |
Why?
| | Microbial Viability | 1 | 2009 | 79 | 0.080 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2014 | 452 | 0.080 |
Why?
| | Aging | 1 | 2018 | 1620 | 0.080 |
Why?
| | Anti-Bacterial Agents | 3 | 2012 | 1477 | 0.070 |
Why?
| | Female | 3 | 2023 | 59507 | 0.070 |
Why?
| | Complement System Proteins | 1 | 2009 | 285 | 0.070 |
Why?
| | RNA, Viral | 2 | 2006 | 566 | 0.070 |
Why?
| | CD4 Lymphocyte Count | 1 | 2006 | 257 | 0.060 |
Why?
| | Klebsiella Infections | 1 | 2005 | 23 | 0.060 |
Why?
| | Pneumonia, Bacterial | 1 | 2005 | 106 | 0.060 |
Why?
| | Viral Load | 1 | 2006 | 405 | 0.060 |
Why?
| | HIV Protease Inhibitors | 1 | 2004 | 64 | 0.060 |
Why?
| | Principal Component Analysis | 1 | 2004 | 176 | 0.060 |
Why?
| | Virus Latency | 1 | 2004 | 80 | 0.060 |
Why?
| | Brain | 1 | 2014 | 2374 | 0.050 |
Why?
| | Carbon Cycle | 1 | 2020 | 8 | 0.040 |
Why?
| | Phycobilisomes | 1 | 2020 | 3 | 0.040 |
Why?
| | Synechococcus | 1 | 2020 | 4 | 0.040 |
Why?
| | T-Lymphocytes | 2 | 2006 | 1745 | 0.040 |
Why?
| | Sensitivity and Specificity | 1 | 2004 | 1691 | 0.040 |
Why?
| | Policy | 1 | 2021 | 137 | 0.040 |
Why?
| | Organelles | 1 | 2020 | 51 | 0.040 |
Why?
| | Fluorescence | 1 | 2020 | 148 | 0.040 |
Why?
| | Cell Nucleus | 1 | 2021 | 554 | 0.040 |
Why?
| | Carbon Dioxide | 1 | 2020 | 218 | 0.040 |
Why?
| | Light | 1 | 2020 | 336 | 0.040 |
Why?
| | Complement C3 | 2 | 2009 | 189 | 0.030 |
Why?
| | Receptors, Metabotropic Glutamate | 1 | 2014 | 34 | 0.030 |
Why?
| | Dendritic Spines | 1 | 2014 | 49 | 0.030 |
Why?
| | Mice | 2 | 2008 | 14916 | 0.030 |
Why?
| | Amidohydrolases | 1 | 2013 | 28 | 0.030 |
Why?
| | Receptor Cross-Talk | 1 | 2013 | 20 | 0.030 |
Why?
| | Quality Improvement | 1 | 2020 | 951 | 0.030 |
Why?
| | Equipment Contamination | 1 | 2013 | 54 | 0.030 |
Why?
| | Central Venous Catheters | 1 | 2013 | 39 | 0.030 |
Why?
| | Polysaccharides, Bacterial | 1 | 2013 | 66 | 0.030 |
Why?
| | Culture Media | 1 | 2012 | 155 | 0.020 |
Why?
| | Bacteriological Techniques | 1 | 2012 | 65 | 0.020 |
Why?
| | Colorado | 1 | 2021 | 4086 | 0.020 |
Why?
| | Attention | 1 | 2014 | 394 | 0.020 |
Why?
| | Trans-Activators | 1 | 2013 | 368 | 0.020 |
Why?
| | Complement Activation | 1 | 2013 | 340 | 0.020 |
Why?
| | Opsonin Proteins | 1 | 2009 | 25 | 0.020 |
Why?
| | Microscopy, Confocal | 1 | 2011 | 305 | 0.020 |
Why?
| | Serum | 1 | 2009 | 57 | 0.020 |
Why?
| | Health | 1 | 2009 | 74 | 0.020 |
Why?
| | Luminescent Measurements | 1 | 2009 | 74 | 0.020 |
Why?
| | Cyclophosphamide | 1 | 2008 | 217 | 0.020 |
Why?
| | Diet | 1 | 2014 | 1080 | 0.020 |
Why?
| | RNA, Messenger | 1 | 2014 | 2557 | 0.020 |
Why?
| | Models, Immunological | 1 | 2006 | 92 | 0.020 |
Why?
| | Serratia Infections | 1 | 2005 | 6 | 0.020 |
Why?
| | Galactose | 1 | 2005 | 20 | 0.020 |
Why?
| | Serratia marcescens | 1 | 2005 | 12 | 0.020 |
Why?
| | Monte Carlo Method | 1 | 2006 | 137 | 0.020 |
Why?
| | T-Lymphocytes, Cytotoxic | 1 | 2006 | 155 | 0.020 |
Why?
| | Mice, Mutant Strains | 1 | 2005 | 271 | 0.020 |
Why?
| | Sepsis | 1 | 2009 | 508 | 0.010 |
Why?
| | Pregnancy | 1 | 2014 | 5525 | 0.010 |
Why?
| | Logistic Models | 1 | 2006 | 1843 | 0.010 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2006 | 965 | 0.010 |
Why?
| | Mutation | 1 | 2005 | 3350 | 0.010 |
Why?
| | Lung | 1 | 2005 | 3546 | 0.010 |
Why?
|
|
Bortz's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|